This research group, led by Professor Marylyn Addo, initiates and coordinates translational research in the field of emerging infections with a particular focus on Ebola, MERS, Lassa and Crimean-Congo haemorrhagic fever. Immunology studies, vaccine development, testing of novel anti-infectives and outbreak management are at the core of their studies. For example, the group was involved in developing an Ebola vaccine which is now being tested further in Africa. A clinical trial investigating a new MERS vaccine is currently being conducted. A group led by Munoz-Fontela uses animal models and conducts clinical trials in Africa to understand the physiology of immune responses to these viruses.